Stannous Fluoride
| Evidence Level: L5 | Predicted Indications: 1 |
Table of Contents
Stannous Fluoride: From Dental Care Products to Meningococcal Infection
One-Sentence Summary
Stannous fluoride is a fluoride compound used topically in dental products such as toothpaste. The TxGNN model predicts it may be effective for meningococcal infection, but there are currently 0 clinical trials and 0 publications supporting this direction, so it is a computational hypothesis only.
Quick Overview
| Item | Content |
|---|---|
| Original Indication | No approved indication text is available (marketed as dentifrice/toothpaste products) |
| Predicted New Indication | Meningococcal infection |
| TxGNN Prediction Score | 99.66% |
| Evidence Level | L5 |
| US Market Status | Cancelled only |
| Number of NDAs | 2 |
| Recommended Decision | Hold |
Why is This Prediction Reasonable?
Currently, detailed mechanism of action data is not available. Based on known information, stannous fluoride is used topically in dental products, where it has antibacterial and anti-plaque activity. Its mechanistic applicability to meningococcal infection has not been established.
Meningococcal infection is caused by Neisseria meningitidis, an invasive systemic pathogen. The antibacterial action of stannous fluoride in the mouth occurs at high local concentrations on the teeth and gums. No data compiled for this report show that comparable concentrations can be reached in the blood or cerebrospinal fluid, or that the compound acts against this organism.
The only support for this prediction is the high knowledge-graph score (0.997). It should be treated as a hypothesis to be tested, not as a finding.
Clinical Trial Evidence
Currently no related clinical trials registered.
Literature Evidence
Currently no related literature available.
US Market Information
| Authorization Number | Product Name | Dosage Form | Approved Indication |
|---|---|---|---|
| M021 | Crest Pro Health | Paste, dentifrice | Not stated (status: cancelled) |
| M022 | parodontax | Paste | Not stated (status: cancelled) |
Safety Considerations
- Knowledge-graph contraindication signal: The knowledge graph links stannous fluoride to dental fluorosis. This comes from graph relationships, not from product label text.
- Drug Interactions: No interactions were found in the queried data.
Please refer to the package insert for other safety information, including warnings and contraindications.
Conclusion and Next Steps
Decision: Hold
Rationale: The prediction rests only on a model score, with no clinical trials, no literature and no mechanistic rationale. Stannous fluoride is a topical dental agent, and systemic activity against Neisseria meningitidis is not supported by any available data. Both US products are also cancelled.
To proceed, the following is needed:
- Mechanism of action data for stannous fluoride
- In vitro evidence of activity against Neisseria meningitidis at achievable concentrations
- Evidence on whether systemic or otherwise relevant exposure is feasible, since current products are topical or oral-care only
- Package insert warnings and contraindications for safety screening
- A review of the dental fluorosis signal, especially if any non-topical use were considered
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.